Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared a post on LinkedIn:
“There’s no doubt TIL therapy has had a tangible impact on melanoma, but the potential of this therapy does not end here. I sat down with City of Hope surgeon Kelly Mahuron to discuss the latest research in this space. Listen to the link below!”
More posts featuring Sumanta Pal on OncoDaily.